Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?

Publisher Summary This chapter discusses the prefrontal cell pathology in major depression as it relates to biochemical and structural changes detected in studies of the serotonergic and noradrenergic neurons located in the brainstem. Information pertaining to both current and lifetime psychiatric symptoms was gathered using the schedule for affective disorders and schizophrenia. State-of-the-art morphometric and stereological methods were used to assess neuronal and glial cell densities, cell body size and cortical thickness in each of the three prefrontal regions. The validity of studies described is underscored by the fact that the tissues from the prefrontal cortex and brainstem nuclei were examined in the same depressives and control subjects. The cellular changes described in these postmortem studies indicate that both types of brain cells, neurons and glia, are involved in the cortical pathology of major depression. It remains to be determined whether the morphometric changes detected postmortem in subjects with major depressive disorder are trait or state dependent, and whether antidepressant medications have an effect on cell morphology. In the present study, cell pathology was detected even in those subjects who were not taking antidepressant medications; however, further behavioral and morphometric experiments on animals treated with antidepressant medications will shed more light on this issue.

[1]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[2]  P. Goldman-Rakic The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[3]  G. Aghajanian,et al.  Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons , 1993, Brain Research.

[4]  I. Heuser,et al.  The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. , 1992, Progress in brain research.

[5]  A. Biegon,et al.  Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicide. , 1990, Archives of general psychiatry.

[6]  P. Rakic,et al.  Three‐dimensional counting: An accurate and direct method to estimate numbers of cells in sectioned material , 1988, The Journal of comparative neurology.

[7]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[8]  P. Magistretti,et al.  Metabolic coupling between glia and neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  P. Goldman-Rakic,et al.  107 Marked glial neuropathology in prefrontal cortex distinguishes bipolar disorder from schizophrenia , 1997, Schizophrenia Research.

[10]  V. Klimek,et al.  Distribution ofα2-adrenoceptors in the human locus coeruleus , 1996, Brain Research.

[11]  D F Swaab,et al.  Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. , 1995, The American journal of psychiatry.

[12]  H. Meltzer,et al.  Psychopharmacology : the third generation of progress , 1987 .

[13]  S. Sesack,et al.  Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. , 1998, Cerebral cortex.

[14]  T. Robbins,et al.  The prefrontal cortex: Executive and cognitive functions. , 1998 .

[15]  Patricia S. Goldman-Rakic,et al.  Quantitative Three-Dimensional Analysis of the Catecholaminergic Innervation of Identified Neurons in the Macaque Prefrontal Cortex , 1997, The Journal of Neuroscience.

[16]  P. Skolnick,et al.  Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. , 1994, The Journal of pharmacology and experimental therapeutics.

[17]  D. Lewis,et al.  Parvalbumin‐immunoreactive axon terminals in macaque monkey and human prefrontal cortex: Laminar, regional, and target specificity of type I and type II synapses , 1999, The Journal of comparative neurology.

[18]  H. Barbas,et al.  Topographic Organization of Connections between the Hypothalamus and Prefrontal Cortex in the Rhesus Monkey , 2022 .

[19]  J. Kimura,et al.  Cellular localization of brain-derived neurotrophic factor-like immunoreactivity in adult monkey brain , 1999, Brain Research.

[20]  S. Foote,et al.  The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  D. Swaab,et al.  Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. , 1996, Archives of general psychiatry.

[22]  R. Duman,et al.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  P S Goldman-Rakic,et al.  Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.

[24]  P. Goldman-Rakic,et al.  Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. , 1993, Cerebral cortex.

[25]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[26]  J. Tepper,et al.  Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphé serotonergic neurons , 1996, Brain Research.

[27]  P. Skolnick,et al.  Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. , 1993, The Journal of pharmacology and experimental therapeutics.

[28]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P S Goldman-Rakic,et al.  D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Skolnick,et al.  Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. , 1993, European journal of pharmacology.

[31]  M E Greenberg,et al.  Requirement for BDNF in activity-dependent survival of cortical neurons. , 1994, Science.

[32]  H. Gundersen Stereology of arbitrary particles * , 1986, Journal of microscopy.

[33]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[34]  J. Siuciak,et al.  BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration , 1996, Brain Research.

[35]  D. Lewis The catecholaminergic innervation of primate prefrontal cortex. , 1992, Journal of neural transmission. Supplementum.

[36]  G. Rajkowska,et al.  Immunohistochemistry of neural markers for the study of the laminar architecture in celloidin sections from the human cerebral cortex , 1999, Journal of Neuroscience Methods.

[37]  J. Mendlewicz,et al.  Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex , 1997, British Journal of Psychiatry.

[38]  H. Meltzer,et al.  β-Adrenergic receptor binding in frontal cortex of suicide victims , 1991, Biological Psychiatry.

[39]  V. Arango,et al.  Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.

[40]  G. Rajkowska,et al.  Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity , 1998, The Journal of Neuroscience.

[41]  P. Goldman-Rakic,et al.  Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. , 1993, Cerebral cortex.

[42]  V. Arango,et al.  Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims , 1999, Biological Psychiatry.

[43]  J. Fuster The Prefrontal Cortex , 1997 .

[44]  G. Nowak,et al.  Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims , 1995, Brain Research.

[45]  P S Goldman-Rakic,et al.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. , 1995, Cerebral cortex.

[46]  J. Haycock,et al.  Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression , 1999, Biological Psychiatry.

[47]  P. Skolnick,et al.  Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. , 1990, European journal of pharmacology.

[48]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[49]  S. Koslow,et al.  Catecholamine metabolism and disposition in healthy and depressed subjects. , 1987, Archives of general psychiatry.

[50]  Karl J. Friston,et al.  Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions , 1993, Psychological Medicine.

[51]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  P S Goldman-Rakic,et al.  Light and electron microscopic characterization of dopamine‐immunoreactive axons in human cerebral cortex , 1992, The Journal of comparative neurology.

[53]  P. Goldman-Rakic,et al.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. , 1995, Cerebral cortex.

[54]  P. Goldman-Rakic,et al.  Functional and anatomical aspects of prefrontal pathology in schizophrenia. , 1997, Schizophrenia bulletin.

[55]  A. Prange THE PHARMACOLOGY AND BIOCHEMISTRY OF DEPRESSION. , 1964, Diseases of the nervous system.

[56]  P. Goldman-Rakic,et al.  Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy , 1996, The Journal of comparative neurology.

[57]  E. Perry,et al.  Postmortem Neurochemical Studies in Depression , 1986, Annals of the New York Academy of Sciences.

[58]  E. Robins,et al.  Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. , 1987, Archives of general psychiatry.

[59]  J. Morrison,et al.  Noradrenergic innervation of monkey prefrontal cortex: A dopamine‐β‐hydroxylase immunohistochemical study , 1989, The Journal of comparative neurology.

[60]  H. Meltzer,et al.  Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.

[61]  J. García-Sevilla,et al.  α 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression , 1992, Biological Psychiatry.

[62]  André Luxen,et al.  Frontal and parietal metabolic disturbances in unipolar depression , 1994, Biological Psychiatry.

[63]  S. Pappatà,et al.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.

[64]  G. Ordway,et al.  Agonist Binding to α2‐Adrenoceptors Is Elevated in the Locus Coeruleus from Victims of Suicide , 1994 .

[65]  G. Rajkowska Morphometric Methods for Studying the Prefrontal Cortex in Suicide Victims and Psychiatric Patients , 1997, Annals of the New York Academy of Sciences.

[66]  G. Aghajanian,et al.  5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex , 1997, The Journal of Neuroscience.

[67]  D. Overstreet,et al.  Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories , 1991, Synapse.

[68]  J. Price,et al.  Prefrontal cortical projections to the hypothalamus in Macaque monkeys , 1998, The Journal of comparative neurology.

[69]  S. Whittemore,et al.  BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain , 1998, Journal of neuroscience research.

[70]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[71]  P. Goldman-Rakic,et al.  The anatomy of dopamine in monkey and human prefrontal cortex. , 1992, Journal of neural transmission. Supplementum.

[72]  C. Bowden,et al.  Psychomotor performance and monoamine function in bipolar and unipolar affective disorders , 1999, Biological Psychiatry.

[73]  J. Haycock,et al.  Elevated Tyrosine Hydroxylase in the Locus Coeruleus of Suicide Victims , 1994, Journal of neurochemistry.

[74]  Y. Agid,et al.  An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease , 1999, Neuroscience.

[75]  H. Meltzer,et al.  Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain , 1996, Brain Research.

[76]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[77]  S. Sesack,et al.  Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA‐immunoreactive dendrites in rat and monkey cortex , 1995, The Journal of comparative neurology.

[78]  M J Campbell,et al.  The monoaminergic innervation of primate neocortex. , 1986, Human neurobiology.

[79]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[80]  J. John Mann,et al.  Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.

[81]  C. Altar,et al.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[82]  C. Montigny,et al.  Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.

[83]  J. Fuster Prefrontal Cortex , 2018 .

[84]  S. Sesack,et al.  Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. , 1998, Advances in pharmacology.

[85]  S. Sesack,et al.  Ultrastructural associations between dopamine terminals and local circuit neurons in the monkey prefrontal cortex: a study of calretinin-immunoreactive cells , 1995, Neuroscience Letters.